Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. [electronic resource]
Producer: 20080414Description: 748-57 p. digitalISSN:- 0008-543X
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Breast Neoplasms -- drug therapy
- Cohort Studies
- Colorectal Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Genotype
- Humans
- Incidence
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutagenesis, Insertional
- Neoplasms -- drug therapy
- Netherlands -- epidemiology
- Peptidyl-Dipeptidase A -- genetics
- Polymorphism, Genetic
- Proportional Hazards Models
- Prostatic Neoplasms -- drug therapy
- Renin-Angiotensin System -- drug effects
- Risk Assessment -- statistics & numerical data
- Sequence Deletion
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.